Nuclear Medicine and Neurooncology (NMN)
@NMNSymposium
Followers
208
Following
1K
Statuses
1K
Advancing Nuclear Medicine and Neurooncology through research and education. Join the #NMN2025 Symposium on May 09/10th 2025 in Vienna, Austria.
Vienna, Austria
Joined January 2024
🚨Submit your ✍️abstract on #PET imaging or #theranostic treatments of #NMN2025 by February 2nd: and discuss your 🔬science with colleagues from all over the world 🌍!
0
1
1
Original publication by @KeyJ1812 et al: Measurable disease as baseline criterion for response assessment in glioblastoma: A comparison of PET -based (PET RANO 1.0) and MRI-based (RANO) assessments
đź“»Listen to the @NeuroOnc podcast with @ProfNAlbert on measurable disease per FET-PET vs MRI in glioblastoma: #btsm @EANOassociation @NeuroOnc @OncoAlert @oncodaily
0
2
6
đź“»Listen to the @NeuroOnc podcast with @ProfNAlbert on measurable disease per FET-PET vs MRI in glioblastoma: #btsm @EANOassociation @NeuroOnc @OncoAlert @oncodaily
0
4
10
RT @nlinmd: BIG-NCTN is excited to collaborate with @ABCGlobalAll on the brain Mets HUB! If you have suggestions for links/webpages to incl…
0
15
0
RT @DrJNaidoo: Important paper on CNS activity of Ipi-Nivo for Melanoma Brain Metastases after prior antiPD1 @JAMAOnc: - 28pts - CNS ORR 1…
0
23
0
🏆Record number of abstracts submitted already for #NMN2025 and still two days to go until he submission deadline. Submit YOUR abstract on Neuro-Oncology and Nuclear Medicine by midnight Feb 09th and join us:
0
0
2
RT @deroose_c: Acces to #RadioligandTherapy in Europe 🇪🇺 : what are the challenges and what will the future bring? Accès à la #RIV imen Eu…
0
1
0
RT @EditorNeuro: Read the new NOA article summarizing the current state of #methylation profiling of #CNSTumors from an international panel…
0
8
0
RT @joshuapalmermd: Great review on the use of PET imaging for CNS tumors lead by Dr. Breen at Mayo and @MichelleMKimMD at Michigan. CHECK…
0
12
0
RT @SNM_MI: Time for the February 2025 @JournalofNucMed highlights: The State of the Art: Dosimetry Software for Theranostic Applications…
0
1
0
⏰ #NMN2025 abstract submission deadline extended until Feb 09: Thanks for the many submissions already received, exciting data in Neuro-Oncology and Nuclear Medicine to be shared at the meeting! Join us! #btsm #theranostics
0
0
2
RT @Dr_N_Moss: CNS mets=increasingly the main challenge in HER2+ #breastcancer. Here we show that fully 55% of pts w/such spread suffer CNS…
0
13
0
RT @CzerninJohannes: Side-by-Side Comparison of the In Vivo Performance of [212Pb]Pb-DOTAMTATE and Other SSTR2-Targeting Compounds | Journa…
0
2
0
Radiotheranostic landscape: A review of clinical and preclinical development. #theranostics @EANM_NucMed @EanmOncology
0
3
5
RT @CD_AACR: Mini Review: Cancer Neuroscience of Brain Tumors: From Multicellular Networks to Neuroscience-Instructed Cancer Therapies http…
0
30
0
RT @ICOMeningioma: Some of our #ICOM members recently published an article providing practice guideline/procedure standards for diagnostics…
0
4
0
RT @gminniti2012: Radioligand therapy Is emerging as a promising treatment for meningiomas.. hopefully randomized trials Will be able to de…
0
3
0
RT @CD_AACR: Review: Nerves at Play: The Peripheral Nervous System in Extracranial Malignancies By Paola D. Vermee…
0
6
0
Spatially resolved transcriptomics and graph-based deep learning improve accuracy of routine CNS tumor diagnostics. #btsm #neuropathology @sahm_lab @NatureCancer
0
3
2